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This paper outlines the advantages and disadvantages of using high throughput NMRmetabolomics for nutri-
tional studies with emphasis on the workﬂow and data analytical methods for generation of new knowledge.
The paper describes one-by-one the major research activities in the interdisciplinary metabolomics platform
and highlights the opportunities that NMR spectra can provide in future nutrition studies. Three areas
are emphasized: (1) NMR as an unbiased and non-destructive platform for providing an overview of the
metabolome under investigation, (2) NMR for providing versatile information and data structures for multi-
variate pattern recognition methods and (3) NMR for providing a unique ﬁngerprint of the lipoprotein status
of the subject. For the ﬁrst time in history, by combining NMR spectroscopy and chemometrics we are ableNutrition to perform inductive nutritional research as a complement to the deductive approach.
© 2013 Elsevier Ltd. All rights reserved.Nutri-metabolomics1. Introduction
The interplay between dietary intake and health/disease has been
investigated for many years with gradually more reﬁned measuring
methods. Consumption of nutrients and other bioactive compounds
from food interacts with numerous targets, metabolic pathways and
functions in the organism and hereby potentially reduce or increase
the risk of disease. Methods that can handle multiple responses may
therefore be particularly beneﬁcial compared to the classical univari-
ate approaches most often used in nutrition research. Many lifestyle
related problems are in reality metabolic issues: a mismatch between
what is ingested and the needs of the organism. Food health and safe-
ty are areas reaping the beneﬁts of metabolomics. Food is eaten as a
whole and therefore the combined effect of components has to be
taken into account when assessing the health and safety aspect of
food and food processes. Nutritional metabolomics has the potential
to deal effectively with complex nutritional problems as it allows to
explore the metabolic effect of, for example, a speciﬁc food challenge
in a more global way than with traditional nutritional methods
(Scalbert et al., 2009). While genomics concerns the analysis of indi-
vidual genes and thus the inherited potential of what can happen
in a given biological system, metabolomics concerns the analysis of
small molecule intermediates and products of metabolism present
in bioﬂuids, tissues and cellular extracts and thus represent its actual
state (Giovane, Balestrieri, & Napoli, 2008).
The word metabolome was introduced for the ﬁrst time in 1998 by
Oliver, Winson, Kell, and Baganz (1998) as the set of low-molecular-
mass compounds synthesized by an organism (metabolites). The termrights reserved.metabonomics was shortly thereafter introduced by Nicholson, Lindon,
and Holmes (1999) and describes the analysis of changes in the meta-
bolic status of an organism, as a consequence of drug treatment,
environmental inﬂuences, nutrition, lifestyle, genetic effects, toxic
exposure, diseases, etc. A fewyears later the termmetabolomicswas in-
troduced, as the identiﬁcation and quantiﬁcation of every singlemetab-
olite in a biological system (Fiehn, 2002). The two terms metabolomics
and metabonomics are nowadays often used intertwined and the word
metabolomics is now more widely accepted. The human metabolome
does not only include metabolites produced by cells or tissues in the
host or foreign metabolites derived from e.g. drugs, but it also includes
metabolites derived from digestion of food and metabolites produced
by the gut microbiota (Martin, Collino, & Rezzi, 2011). Altogether, this
leaves a complex metabolome signature depending on genetics and
on diet as well as environmental variations that the host has been ex-
posed to. The exact number of small metabolites (b1,500 Da) from
humans is unknown, but has been estimated to be around 20,000
with wide concentration ranges spreading over nine orders of magni-
tude (Giovane et al., 2008). Together these numbers makes analysis of
the complete human metabolome a nearly insurmountable challenge.
The driving force behind the development of metabolomics was signif-
icant developments in analytical platforms such as nuclear magnetic
resonance spectroscopy (NMR) and mass spectrometry (MS). Today,
the situation is turned upside down and it is now the quest to unravel
the metabolome that is the driving force behind development of new
instrumentation.
Nutritional metabolomics is metabolomics applied to the study of
the human (or animal) metabolome as a function of nutritional status
or as a function of a nutritional challenge. Metabolomic analyses
is normally conducted on bioﬂuids, such as blood, urine or faeces
samples. The prospects of nutritional metabolomics are immense as
1132 F. Savorani et al. / Food Research International 54 (2013) 1131–1145it provides an effective tool for objectively monitoring the human
metabolic response to dietary interventions and lifestyle habits. Func-
tional foods are expected to play a major role in preventing lifestyle
related problems in the future (Katan & De Roos, 2004) and research
on the relation between the human metabolome, nutrition, and
health holds great promise for investigating and understanding bio-
markers for food intake and lifestyle diseases (Rezzi et al., 2007).
The ﬁrst published study, in which the metabolomics approach was
used in a nutritional experiment, applied NMR technology to measure
the effect of dietary soy supplementation (Solanky et al., 2003), and
after this several other NMR-based nutritional metabolomic studies
have been conducted, e.g. Holmes et al. (2008), Lenz et al. (2004),
Stella et al. (2006). MS-based nutritional metabolomics had its begin-
ning a little later with one of the ﬁrst studies investigating polyphenol
concentrations in human urine after intake of polyphenol-rich bever-
ages (Ito et al., 2005), andmore studies have followed (Fardet, Llorach,
Martin, et al., 2008; Fardet, Llorach, Orsoni, et al., 2008; Shen et al.,
2008). This paper aims at providing a quick introduction to the nutri-
tional metabolomics work ﬂow, studying the fate and mechanisms of
bioactive components in food with particular focus on strengths and
weaknesses of using the NMR analytical platform.
2. The nutritional metabolomics platform
The increasing interest towards metabolomics and metabonomics
takes advantage from the nuclear magnetic resonance (NMR) spec-
troscopy that in many cases is able to replace laborious and time
consuming chemical analysis, providing a comprehensive overview
over the gross chemical (and physical) features of the samples. To ob-
tain fruitful and reliable results from metabolomic studies, numerous
factors have to be carefully considered. These aspects are summarized
in Fig. 1, which illustrates the workﬂow of a metabolomic study.
3. Hypothesis
In society there is a massive quest towards healthy diets: (1) peo-
ple want to eat healthy to increase their well-being, (2) society wants
people to eat healthy to reduce cost for the public health sector,
(3) doctors would like to be able to give diet recommendations
based on scientiﬁc evidence and (4) the food industry wants to be
able to give health claims on their products in order to maximize
their proﬁts. The study and reﬁnement of human nutrition will thus
continue to have strong push from society and industry. In nutritional
metabolomics the aim is usually to investigate the perturbation
of the human metabolome by a certain diet or a certain bioactive
compound. For the industry the prospects of using metabolomics for
establishing nutritional beneﬁts and health claims is considerable,Fig. 1. The workﬂow of a nutritional metabolomics study: hypothesis, experimental design,
analysis and the biological interpretation.but serious challenges remain ahead. For example: How do we deﬁne
health in the absence of disease? (Huber et al., 2011). Measuring
(more) metabolites in a more sensitive manner in healthy subjects
does not alwaysmean providingmore information and, for nutritional
metabolomics, an important driver is the lack of success to observe
effects of dietary interventions on proﬁles obtained in homeostasis
in healthy subjects. Interestingly, health has recently been redeﬁned
to be the body's ability to recover after a given (nutritional) challenge
and the way out for nutritional metabolomics is to assess dynamics
upon perturbations, which might help metabolomics to develop new
biomarkers beyond the well-established blood pressure and choles-
terol numbers (Holmes et al., 2008; Llorach, Garcia-Aloy, Tulipani,
Vazquez-Fresno, & Andres-Lacueva, 2012).
4. Experimental design
Metabolomic proﬁling seeks to determine as many chemical (and
physical) features as possible and to identify metabolites or patterns
of metabolites that discriminate samples from treated individuals
and controls (Fiehn, 2002). Experimental design is about maximizing
the possibilities of obtaining signiﬁcant results in relation to the hy-
pothesis investigated. There is in principle no difference between
a nutri-metabolomic study and a more traditional nutrition study ex-
cept that the data output will be multivariate. This is unambiguously
to be considered as a huge advantage because biological systems are
complex multivariate systems and because multivariate responses
will allow much more rigorous result validation.
The human organism can be considered as a multivalent sink ca-
pable of converting about all biological materials to energy. However,
on the detailed chemical and kinetic level there is a great intra- and
inter-individual variation in efﬁciency and speciﬁcity. In order to
deal with this a number of key-issues deserve particular attention
before conducting an intervention study. Firstly, it is particularly im-
portant to control the dietary intake due to the large diversity of com-
pounds present in different food items. Metabolomics studies have
shown that already after 24 h, the subjects remain in their metabolic
space and that the remaining intra-and intersubject variations appear
to be inﬂuenced by variables such as genetics, age, and lifestyle
(Winnike, Busby, Watkins, & O'Connell, 2009), while experiments
with urine samples have shown that diet standardization during
3 days reduce inter- and intra-individual variation and that effects
of diet culture and cohabitation were signiﬁcantly attenuated after
diet standardization (Rasmussen et al., 2011). Secondly, because of
the high inter-individual variation, a full cross-over design should
be preferred to parallel studies (Scalbert et al., 2009) as it gives the
possibility to observe and compare the individual with and without
intervention. And thirdly, different metabolomes display differentsampling of bioﬂuids, the analytical platform, the sample spectra, the multivariate data
1133F. Savorani et al. / Food Research International 54 (2013) 1131–1145kinetics upon a given challenge. The most commonly used biological
samples for obtaining metabolic snapshots are the easy accessible
samples such as urine, saliva, faeces and blood/plasma/serum
(Giovane et al., 2008), and their metabolite and sampling dynamics
is an important issue to consider in the study design. In urine there
exists a high diurnal variation (Maher, Zirah, Holmes, & Nicholson,
2007) but it has been shown that postprandial urines had a stable
chemical composition over a period of 2–4 h after eating a stan-
dardized breakfast, suggesting that there is a ﬂexible time window
for urine collection (Fave et al., 2011). In serum the efﬁcient human
homeostasis will effectively restore the status quo and in faeces
there is a signiﬁcant pooling effect and samples thus represent a sum-
mary of the previous 24 h (or so) solid state waste. Recently, partly
because of the change in the health deﬁnition and partly because
of new measurement and data analysis opportunities, the response
kinetics of the metabolome upon a nutritional challenge has been
favoured from the previous more static approaches based on a single
or a few samples along the time line of the intervention (van Ommen,
Keijer, Heil, & Kaput, 2009).
In any case, experimental design should be thoroughly discussed
by all the stake-holders in the nutri-metabolomics work ﬂow. By
the clinical nutritionalists, what is the expected level of intra- and
inter-individual variation? By the analytical chemists, what is the
uncertainty of the measurements? By the data analysts, what is the
power of the investigation? By the ethical experts, what is acceptable
to investigate? By the legislators, what are the requirements for
obtaining health claims?
5. Sampling
In humans and animals, biologically relevant samples can routine-
ly be obtained from blood, small tissue biopsies, saliva, urine and
faeces. Nutritional metabolomic experiments are most often designed
to capture one or more time snapshots of the metabolome, and
the primary concern of sampling is to inhibit or stop metabolic ﬂux
to preserve the original information and variance in the biological
sample and to ensure appropriate quantiﬁcation and reproducibility
among samples (Beckonert et al., 2007). Standard operational proce-
dures (SOP) must be developed for the sampling which takes into
consideration all critical sampling issues that may introduce additional
unwanted variation. From a sampling perspective the three main body
ﬂuids represent different challenges and metabolic snapshots. For both
urine and plasma samples the time between collection and processing
should not exceed 2 h and during this time delay samples should be
kept at 4 °C. Longer term storage such as in a biobanking environment5.56.06.57.07.58.08.59.09.5
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Fig. 2. A typical NMR spectrum of human urine acquired at 600 MHz with TCI cryoprobe,
4.05(s)), creatine (3.04(s), 3.93(s)), trimethylamide N-oxide (3.27(s)), dimethylamide (
4.16(q)).should be done at −80 °C (Bernini et al., 2011; Gika, Theodoridis, &
Wilson, 2008).
5.1. Urine samples
Urine can be considered as a hydrophilic human waste stream
generated in the kidneys and containing numerous metabolites. The
urine contains undesirablemetabolites and especially nitrogen richme-
tabolites which have been eliminated from the blood stream. One of the
ﬁrst 1H NMR studies of human urine was performed by Holmes et al.
(1994). A representative spectrum is shown in Fig. 2 including a list of
the major metabolites observed. The most prominent metabolites in
the 1H NMR spectrum of urine are creatinine, creatine, trimethylamide
N-oxide, dimethylamide, citrate and lactate.
Sampling of urine is non-invasive and can be performed either
as spot urine or as a 24 h pooled sample. Irrespective of the collection
method, a urinary preservative and cooled storage conditions (below
5 °C) is recommended (Maher et al., 2007; Rasmussen et al., 2011) as
urine most often will be contaminated with microorganisms. This will
minimise the microbial conversion of metabolites and in this way
keep them representative for the biological situation they originally
derived from. In NMR investigations a proton-free preservative is
preferred to limit interference with 1H NMR spectra, and addition of
NaN3 has been recommended by Lauridsen, Hansen, Jaroszewski,
and Cornett (2007) and Saude and Sykes (2007), who showed that
NaN3 reduced the changes in metabolite concentration when urine
was kept at room temperature. Addition of NaN3 to the sample collec-
tion devices prior to collection is only possible in animal studies
and not in human studies, due to safety issues of this highly toxic
chemical. In 1H NMR analysis of urine samples, special concerns have
to be focused onminimising the sample to sample variation in chemical
shift due to tiny variations in temperature, ionic strength and, above all,
pH. In order tominimize the latter variation a phosphate buffer is some-
times added to the sample.
It must not be forgotten that urine consists mostly of water and
that the dry matter content per volume can severely change among
individuals, but also within the same individual, according to a multi-
plicity of factors that may be summarized into drinking habits, physical
activity, food intake and health status. This represents a challenging
issue that has to be taken into consideration when comparing NMR
metabolomics urine data, since the absolute intensity of themetabolites
will strongly differ among samples (Dieterle, Ross, Schlotterbeck, &
Senn, 2006). Data normalisation tools (see later), but also the adoption
of a standardized regime of the subject habits before sampling, are
common ways for coping with this issue (Rasmussen et al., 2011).1.01.52.02.53.03.54.04.5
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using a 1D NOESY_presat experiment. The main metabolites are creatinine (3.05(s),
2.73(s)), citrate (2.53–2.56, 2.66–2.71 (AB)), glycine (3.57(s)) and lactate (1.34(d),
1134 F. Savorani et al. / Food Research International 54 (2013) 1131–11455.2. Blood samples
Whole blood is composed of blood cells and the liquid medium
ﬂuid: blood plasma. Plasma samples are prepared by removing the
blood cells by spinning with a centrifuge and subsequently add an an-
ticoagulant. The choice of the anticoagulant must be made in order to
avoid unwanted peaks in the 1H NMR spectrum and additionally to
reduce the oxidation of plasma as much as possible. EDTA, heparin
and citrate are the most commonly used anticoagulants. Heparin,
a polysaccharide, has been recommended as the preferred plasma
anticoagulant for NMR metabolomic studies due to low introduction
of interfering peaks (Barton et al., 2010). Serum samples differ from
plasma samples in that they do not contain the protein ﬁbrin which
is responsible for the bloods capability to clot. Blood serum samples,
which are most abundantly used in nutritional metabolomics studies,
are prepared by allowing the blood to clot and subsequently removing
the clot using a centrifuge. A third promising option for collecting
valuable information from blood is to sample erythrocytes or RBC
(red blood cells) which may be suitable for nutritional metabolomics
studies (Darghouth, Koehl, Junot, & Romeo, 2010; Jenab, Slimani,
Bictash, Ferrari, & Bingham, 2009).
Plasma is highly aqueous (92% v/v) and circulates dissolved nutri-
ents, such as glucose, amino acids, and fatty acids (dissolved in the
blood or embedded in the lipoproteins), and removes waste products,
such as carbon dioxide, urea, and lactic acid. The ﬁrst 1H NMR study of
human blood was performed by Bock (1982) on her own blood before
and after ingestion of alcohol (the ﬁrst NMR nutritional metabolomics
study). A representative human blood spectrum (plasma) is shown
in Fig. 3 including assignments of the major metabolites observed.
The most prominent metabolites in the NMR spectrum of blood are
fat (methylene- and methyl-moieties from the lipoproteins), lactate
and glucose. A comprehensive list of metabolites in the human serum
metabolome is given by Nicholson, Foxall, Spraul, Farrant, and Lindon
(1995) and by Psychogios et al. (2011).
Sampling of blood is invasive but can be performed with regular
intervals with a simple drop and will, in contrast to urine, always
have approximately the same dry matter content. When considering
blood sample collection, the microbial aspect is less important than
in urine, but instead enzymatic metabolite degradation can be pro-
nounced. Blood samples should therefore be handled as cold as possi-
ble to preserve themetabolic snapshot in themost optimalway and an
anticoagulant must be added in order to prevent clotting. An excep-
tion to this protocol may be when optimal lipoprotein fractionation
is desired as it has been shown that a single freeze–thaw cycle can
introduce 37% variability in HDL and LDL cholesterol determinations
based on density fractionation (Zivkovic et al., 2009).33.23.43.63.84.04.24.44.64.85.05.25.4
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Fig. 3. NMR spectrum of human plasma acquired at 600 MHz with TCI cryoprobe, using a
methyl: 0.75–0.86; unsaturated chain protons: 5.27–5.40; as well as many others in the r
4.14(q)), alanine (1.49(d)), valine (1.02(d), 1.07(d)) and glucose (3.20–4.00(m), 5.27(d)).Addition of the reference compound 3-trimethylsilylpropionic
acid (TSP), which is normally used in 1H NMR experiments, is not
recommended in plasma or other samples with high protein content
due to protein binding (Cavanagh, Fairbrother, Palmer, & Skelton,
1996) and in turn much reduced signals (Beckonert et al., 2007), be-
sides TSP is also pH dependent (De Marco, 1977). Instead the natural
occurrence of α-glucose can be used as reference compound as
suggested by Pearce et al. (2008). Another solution is to use a quan-
titative reference signal in an electronic manner as provided by the
ERETIC experiment (Akoka, Barantin, & Trierweiler, 1999) which
have become wide spread in quantitative NMR applications. Finally,
it should be mentioned that ultraﬁltration can be used to remove the
broad signals from high-molecular weight species of serum (Tiziani et
al., 2008) and the spectral quality that can be obtained has been proven
superior to other separation methods and spectral editing techniques
(Stolzenburg, Lauridsen, Toft, Zalloua, & Baunsgaard, 2011).
5.3. Face samples
Faces or stool is the major waste stream from the digestive tract.
The chemistry of faeces has been studied for a long time (Emmet
& Grindley, 1909). One of the ﬁrst 1H NMR metabolomic study of
human stool was performed by Marchesi et al. (2007). A representa-
tive healthy human faeces spectrum (from faecal water) is shown in
Fig. 4 (from Marchesi et al) including a list of the major metabolites
observed. The most prominent metabolites in the 1H NMR spectrum
of faeces are n-butyrate, propionate, acetate and glycerol. This study
was rapidly followed by some more in which both human and animal
faeces were investigated by NMR: 1) Martin et al. (2007) using magic
angle spinning NMR (MAS-NMR) on mice whole stool, 2) Saric et al.
(2008) in which a characterization and a comparison between human,
mouse and rat faeces is performed and 3) Jacobs et al. (2008) where
stool samples of human subjects involved in an polyphenol enriched in-
tervention studywere analysedwith 1HNMR,with a particular focus on
the extraction method.
Indeed, obtaining a comprehensively representative sample form
the faecal matter is a challenging operation that severely depends on
the method, the solvent and the physico-chemical conditions chosen
for the extraction. Sampling of stool typically represents the waste
from several days, which may be conserved frozen at −80 °C, and
subsequently extracted with phosphate buffer and the insoluble
ﬁbres spun down. This method produces samples that are mostly
representing the aqueous fraction of faeces (faecal water) but that
do not represent well the whole metabolome contained into the
other factions. Jacobs et al. (2008) introduced a more sophisticated
procedure that has the advantage of providing a more exhaustive0.60.81.01.21.41.61.82.02.22.4.0
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Fig. 4. Human faeces CPMG NMR spectra acquired at 600 MHz of water (D2O) and methanol (MeOD) extracts of freeze-dried whole stool samples (spectra are kindly provided by
Jacobs et al. (2008)). The aromatic and aliphatic regions are displayed with different intensity scales in order to enhance the weaker aromatic signals. The main signals originate from
n-butyrate (0.90(t), 2.16(t), 1.56(m)), propionate (2.19(q), 1.06(t)), acetate (1.91(s)), and glycerol (3.56(dd), 3.64(dd), 3.87(m)) and the lipid resonances (1.30, 5.36) together with
the cholate one (0,71(s), 1,02(s)) for the methanol extract spectrum. Water extracts result best for recovering SCFAs and small organic acids while methanol extracts are preferable
when the focus has to be on lipids and small phenolic acids.
1135F. Savorani et al. / Food Research International 54 (2013) 1131–1145extraction which represents better all the metabolites contained
in the faeces. This method requires an initial freeze-drying step
followed by a series of extractions and centrifugation steps to re-
move the insoluble fractions. Eventually, a targeted solvent (water
or methanol) can be used for obtaining a different metabolic proﬁle
extraction according to the aims of the study. pH also strongly
affects the metabolites that will be present in the ﬁnal samples and a
pH value higher than 7 or lower than 5 is suggested for enhancing
the extraction of short chain fatty acids (SCFAs) or phenolic acids,
respectively.
6. Analytical platform
The human metabolome is kept within a tight homeostatic
bandwith, and in a healthy state perturbations of homeostasis
are restored quickly. Recording real-time metabolic dynamics upon
perturbations represents a challenge for the analytical methods
employed. Liquid chromatography–mass spectrometry (LC-MS), gas
chromatography–mass spectrometry (GC-MS) and 1H NMR spectros-
copy are the most suited and commonly most used platforms for
metabolomic studies (Oresic, 2009) and most interestingly they are
highly complementary techniques with very little analytical overlap
(Psychogios et al., 2011). 1H NMR is by far the most rapid analytical
platform for nutritional metabolomics research as it requires only
minimal sample handling and because the 1D NMR spectrum can
generally be acquired in a few minutes. LC-MS has much higher sen-
sitivity but is biased both at the chromatographic (use of separation
principle and material) and mass spectra (use of ion-trap, time of
ﬂight, Mw) approach. Nevertheless, the literature contains plenty
of successful MS-based untargeted metabolomics studies. The use
of MS alone, such as QTOF, adds a factor of 2–3 orders of magnitude in
sensitivity compared to NMR and the reported much higher sensitivi-
ties of the LC-MS stems from the use of chromatographic separation
(and up-concentration) of the compounds present in a complexmatrix,
which can be equally well conducted by hyphenated NMR such as
LC-NMR or cap-NMR (Jaroszewski, 2005; Spraul, Hofmann, Dvortsak,
Nicholson, & Wilson, 1993; Wolfender, Ndjoko, & Hostettmann, 2001).
At the bottom line, the analytical platforms are very complementary
and the most successful metabolomic studies employ a broad range of
analytical techniques and integrate the data to give the broadest possi-
ble coverage of the metabolome under study.High-resolution NMR spectroscopy is capable of providing de-
tailed information on solution state molecular structures based on
atom nuclear interactions and properties. The principle of NMR is
based on the fact that certain atomic nuclei have spin properties
that, under exposure to an external magnetic ﬁeld, lead to a splitting
of their energy levels, which is proportional to the strength of the
magnetic ﬁeld. Under the presence of an external magnetic ﬁeld the
nuclei spins will split up and create a small magnetic ﬁeld which
can be manipulated by RF pulses with a frequency that matches this
energy transfer. The precise resonant frequency of the energy transi-
tion is dependent on the effective magnetic ﬁeld at the nucleus, and
this ﬁeld is affected by shielding of electrons orbiting the nucleus.
Consequently, nuclei in different chemical environments absorb ener-
gy at slightly different resonance frequencies, and this effect is re-
ferred to as the chemical shift.
The larger the magnetic ﬁeld the better is the resolution and
sensitivity, but, without pre-concentration, NMR is “only” capable of
detecting metabolites down to the micro-molar concentration range
(Wishart, 2008b). However, the main advantage of NMR is that the
technique is capable of providing a unique inherently quantitative
and un-biased overview of the metabolome under investigation
(no groups of molecules or particular molecular properties will be
suppressed and remain undetected). The value of this cannot be
overestimated as it allows for an inductive and explorative approach
which cannot be misguided by a priori knowledge. In other words,
NMR has the advantage that intensity and concentration are propor-
tional over the majority of the dynamic range and that the recovery is
excellent. The use of NMR in metabolomics is based upon a long tra-
dition in rapid quantitative analysis by spectroscopy (Nitchie, 1929)
which, when combined with chemometrics, have led to a paradigm
shift in industrial quality control (Munck, Nørgaard, Engelsen, Bro,
& Andersson, 1998). As an additional advantage, NMR has unique
properties for measuring for example lipoproteins and chylomicrons
triglycerides content in blood (Dyrby et al., 2005; Otvos, Jeyarajah,
& Bennett, 1991; Savorani, Kristensen, Larsen, Astrup, & Engelsen,
2010) due to its sensitivity to physical phenomena such as diffusion
and rotational motion.
The majority of NMRmetabolomic studies have been using proton
NMR spectroscopy since it is the most informative and sensitive
NMR method and thus the most rapid method suited for high
throughput studies. 1H NMR spectroscopy excels in identifying all
1136 F. Savorani et al. / Food Research International 54 (2013) 1131–1145proton containing compounds in a sample. Because of the high natural
abundance of 1H (~99.985%), its high gyromagnetic ratio and its preva-
lence inmetabolites, this nucleus is themost used for metabolomics ex-
periments in NMR measurements (Beckonert et al., 2007; Moco, Bino,
DeVos, & Vervoort, 2007). The development of instrumentswith higher
magnetic ﬁeld strength and cryogenically cooled probes has pushed the
limits of detection (Keun, 2006), improving their use in non-targeted
metabolomics. In this case, the consequent spectral comparison de-
mands that the spectrum acquisition and control of conditions should
be very precise. Generally, NMR metabolomic studies of bioﬂuids have
shown high reproducibility (Keun et al., 2002) and in most cases only
one analytical replicate is sufﬁcient per time point (Beckonert et al.,
2007). However, small changes in pH, ionic strength, temperature and
presence of precipitate, impurities or degradation of sample material
should be minimised, since these factors may lead to detection of
false metabolic changes and hereby incorrect selection of potential
biomarkers (Moco et al., 2007).
Despite the superiority in information and sensitivity of the basic
1H NMR spectrum other NMR methods have also been investigated
for use in metabolomics. In enriched studies 13C NMR can provide
valuable and complementary information (Keun et al., 2002), but
13C NMR will never become a competitive high throughput method
due to the low abundancy of the 13C isotope. Other trends in NMR
methods go towards pure shift (Aguilar, Faulkner, Nilsson, & Morris,
2010) and J-resolved methods (Yilmaz, Nyberg, & Jaroszewski,
2011) for the enhanced resolution and towards diffusion edited spec-
troscopy (DOSY) (Johnson, 1999) for contrasting close metabolites
in a second dimension (Dyrby et al., 2005; Nilsson, Khajeh, Botana,
Bernstein, & Morris, 2009). In particular the 2D J-resolved (JRES)
NMR experiment has great potential for quantiﬁcation since it re-
quires only a short measurement time and still reduces signal overlap
by separating effects of chemical shift and J-coupling in two dimen-
sions (Ludwig & Viant, 2010). The JRES experiment can be recorded
in an ultrafast (UF) acquisition mode by making use of spatial
encoding instead of conventional time-incrementing in which the
second dimension can be sampled in a single shot, and it is thus
of great interest for compound quantiﬁcation of short time scale
phenomena in concentrated mixtures. Ultra-sensitive and ultra-fast
NMR can also be performed by dynamic nuclear polarization (DNP)
which has great potential for elucidating metabolic reactions in
the picosecond scale, but unfortunately this method is not likely
to be developed as a quantitative high-throughput method (Meier,
Karlsson, Jensen, Lerche, & Duus, 2011). A proof-of-principle that
DNP can indeed be used for quantitative single scan 13C NMR detec-
tion of a drug metabolite in plasma has recently been given (Lerche
et al., 2011).
7. Spectral preprocessing of NMR data
NMR signals are collected as a function of time. The decaying sig-
nal that follows a pulse is called the free induction decay (FID). The
chemical shift can be derived from the FID by utilising a Fourier trans-
formation, whereby the time domain is converted into the frequency
domain. Spectral processing of single NMR spectra will not be con-
sidered here, but the quality of the spectra and thus the quantitative
information in the spectra will depend on the quality and homoge-
neity of the external magnetic ﬁeld (shimming) and on precise and
accurate tuning and matching of the nuclei magnetic resonance fre-
quency (Goodacre et al., 2007). Prior to Fourier transformation the
data is typically zeroﬁlled and apodised to a certain line broadening.
Hereafter, NMR spectra needs to be corrected for deviations from
a ﬂat horisontal baseline and phase errors (Wishart, 2008a). The
employed NMR software can usually do this automatically and it is
tempting to state that current metabolomics research is “beyond the
children diseases” in spectral preprocessing such as (1) zero ﬁlling
and line broadening; (2) chemical-shift referencing; (3) phasing; (4)baseline correction; (5) line-shape correction; (6) pH determination;
and (7) notch/water ﬁltering (Wishart, 2008b).
One of the most valuable features of 1H NMR spectroscopy is that
the observed resonance frequencies are extremely sensitive to the
local chemical environment of the nucleus. It is this property that
causes dispersion of the resonances from the various nuclei in a
molecule across the spectrum, facilitating structural characterization
and the differentiation between various compounds in a mixture.
However, this shift sensitivity also means that resonance frequencies
can be affected by even minor ﬂuctuations in temperature, pH, and
the external magnetic ﬁeld (Pearce et al., 2008), which in turn may
create difﬁculties for the subsequent data analysis and interpretation.
To solve this problem a number of different peak (signal) alignment
methods have been developed (see below).
Moreover, magnet shimming, which is a critical NMR procedure
(automatic or manual) to generate an ideally perfect homogeneous
magnetic ﬁeld over a restricted region of the sample volume in order
to obtain pure lorentzian line shapes, in reality often produces tiny
differences in shim quality between samples which are normally
neglectable. However, if such inhomogeneities are pronounced, refer-
ence deconvolution (Metz, Lam, & Webb, 2000) can signiﬁcantly im-
prove quantitative performance of non-optimal recorded NMR spectra.
8. Multivariate data analysis of NMR metabolomics data
The performance of the combination of NMR spectroscopy with
multivariate data analysis (chemometrics) was already demonstrated
in the early 1980s (Johnels et al., 1983) and has proven to have a tre-
mendous potential for metabonomics (Nicholson et al., 1999; Trygg,
Holmes, & Lundstedt, 2007). In this approach themultivariate analytical
results are compared across large cohorts, for example in intervention
studies, for metabolites and/or patterns of metabolites that are able to
isolate the effect of the intervention.
When collecting large scale NMR metabolomics data basically two
possibilities exist for the subsequent multivariate data analysis:
Metabolic proﬁling: NMR is inherently quantitative and the signal
integrals are directly related to the concentration of the metabo-
lites. For this reason metabolic proﬁling is an obvious choice for
the analysis of large scale metabolomics data sets. In this approach,
as many signals as possible are identiﬁed (not necessary assigned)
and their peaks integrated for each sample. This approach will
generate a data set of the size (number of samples)×(number of
peaks) where the number of peaks usually is in the order of hun-
dred to a few hundreds. An important development in metabolic
proﬁling is targeted proﬁling in which the mixture spectrum is
compared to a library of reference spectra derived from pure com-
pounds of known concentrations and the metabolites thus directly
quantiﬁed (Wishart, 2008b).
Metabolic ﬁngerprinting: In this slightly more explorative approach,
the NMR signals (metabolites) are not initially identiﬁed and all
the spectral features are utilized in the multivariate data analysis.
This approach is often referred to as metabolic ﬁngerprinting, since
the intention is not to identify each observedmetabolite, but instead
to compare ‘ﬁngerprints’ or patterns of changes in response to
e.g. dietary intake or disease status (Dettmer, Aronov, & Hammock,
2007). Subsequently, model interpretation and identiﬁcation of
the selected metabolites is necessary in order to provide biological
insight and understanding of underlying mechanism of action. As
metabolic ﬁngerprinting promotes new and unexpected ﬁndings
and as computational power has increased, there is an increasing
tendency to perform analyses at the maximum spectral resolution
possible (Cloarec et al., 2005b). Metabolic ﬁngerprinting will gen-
erate a data set of the size (number of samples) × (number of spec-
tral variables). The number of spectral variables is usually many
thousands.
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9.1. Data preprocessing
Typically, large scale metabolomics data sets are analysed by
pattern recognition methods such as principal component analysis
(PCA) (Hotelling, 1933) in which many sample spectra are analysed
simultaneously. Irrespective of the chosen data strategy modern
multivariate data analytical strategies will challenge the care and pre-
cision by which the metabolomics NMR data have been generated
and preprocessed. For this reason, chemometrics has been useful in
ﬁnding solutions to imperfect analytical methodology that are prone
to alignment, normalization and other standardization problems as
well as for advanced analysis aimed at exploiting the experimental
design and the data structure (Bro et al., 2010; van Velzen et al., 2008).
Since there is an increasing tendency to perform metabolic pro-
ﬁling at the maximum spectral resolution possible, it is crucial that
shift errors are removed and the spectra accurately calibrated to pre-
vent such variation deteriorating the pattern recognition. In contrast
to normalization, which represents a vertical change to the NMR
data, alignment is a horizontal change to the data. Sometimes spectral
alignment can be avoided by binning (Spraul et al., 1994) in which
many spectral variables are summed to represent only one average
variable. There exist in scientiﬁc literature two commonly used
methods for alignment: compression/expansion (C/E) or insertion/
deletion (I/D). The former implicitly assumes that peak widths can
be correlated to the spectral axis. The latter, on the contrary, assumes
the peak width to be invariant within limited ranges of the spectral
axis and remains unchanged in case of shift. Therefore, the C/E
model is most commonly used in the alignment of chromatographic
signals with methods such as correlation optimised warping (COW)
(Nielsen, Carstensen, & Smedsgaard, 1998) whereas the I/D model
with methods such as recursive segment-wise peak alignment (RSPA
(Veselkov et al., 2009)) and interval correlation optimised shifting
(icoshift) (Savorani, Tomasi, & Engelsen, 2010). Fig. 5 shows an example
of the performance of modern alignment methods which efﬁciently
can eliminate horizontal scaling problems in NMR data.su
cc
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e
Fig. 5. Interval alignment of NMR data using the icoshift tool. The three spectral inter-
vals with gray background are shown before and after the alignment correction.
Having different peak multiplicity, they present very different peak misalignment
severity but are all correctly amended by the algorithm at once as clearly shown espe-
cially for the succinate singlet.Recorded metabolite proﬁles, measured from bioﬂuid data, are
often subject to systematic variations in intensity across all measured
variables in a sample which can mask the biologically-relevant differ-
ences between proﬁles. The sources of obscuring variation may arise
from inhomogeneity of samples, minor differences in sample prepara-
tion, instrumental perturbation and also data extraction steps may in-
troduce an additional error (Sysi-Aho, Katajamaa, Yetukuri, & Oresic,
2007). Data normalisation (vertical scaling between samples) and
scaling between variables is typically applied to remove unwanted
systematic bias in ion- or signal- intensity measurements while
retaining the interesting biological information. The normalisation of
metabolite proﬁles is therefore a process of row-wise standardisation,
intended to remove this spurious between-sample variation from
the data. Paradoxically the risk of any normalisation method is the
possibility of introducing spurious correlations to the data (Capozzi,
Ciampa, Picone, Placucci, & Savorani, 2011), and obviously the chosen
normalisation method can have a decisive effect on the outcome
of subsequent application of pattern-recognition methods. There are
a great number of established methods for normalising metabolite
proﬁles and every method of normalisation is based on certain
assumptions to the nature of the data. Some of the most common
normalisations methods are: (1) unit sample intensity sum; (2) unit
sample vector length (Euclidian norm); (3) probabilistic quotient/
median fold-change (Dieterle et al., 2006); (4) a reference feature
present in all samples at a constant level. The referencing standards
TSP and DSS often provide this, along with chemical-shift referencing
for NMR. However, for the protein rich samples like those derivating
from blood, the TSP protein binding capacity makes it a non-suitable
choice for the normalization purpose. In some cases a good under-
standing of the underlying biology allows the selection of a compound
expected to be stable across the data-set. For example, as far back
as Rose (1933), creatinine has been used as a reference compound in
urine clinical-chemistry, under the assumption that it scales well
with muscle mass; (5) histogram matching (Torgrip, Aberg, Alm,
Schuppe-Koistinen, & Lindberg, 2008) which seek to match the histo-
gram of intensities in a spectrum as closely as possible to that of a
reference spectrum; and (6) entropy related methods. Since any nor-
malizationmethodmay be destructive to the quantitative information
buried in the metabolomics data, it is always recommended to use an
external validation of the normalization method used. This can be op-
timally done if external quantitative knowledge from clinical analysis
is available to the sample set. Then, a simple multivariate regression
(see later) to a given metabolite can evaluate whether the normaliza-
tion deteriorates or improves the correlation. This is for example
shown in the case of creatinine in urine (Rasmussen et al., 2012).
Fig. 6 shows how the regression performance between the NMR
spectra and the externally measured creatinine concentration can be
inﬂuenced by different normalisation methods. The best normalisation
method can then be selected as the one which conserve the creatinine
information best.
9.2. Data pretreatment
Before multivariate data analysis the spectral data is normally
mean-centred in order to focus the analysis on the difference be-
tween the samples rather than the direction of the overall variance.
Mean-centring converts all the signal intensities (metabolite concen-
trations) to ﬂuctuations around zero instead of around the mean
of the signal intensities (metabolite concentrations) and hereby
adjusts for offset variation between the high and low abundant
metabolites (van den Berg, Hoefsloot, Westerhuis, Smilde, & van der
Werf, 2006). Besides this, the addition of a column-wise vertical scaling
method should also be considered in order to adjust for the fold dif-
ference between the detected metabolites. The most commonly used
scaling methods for metabolomics data are autoscaling (scaling to unit
variance) and pareto scaling. The autoscaling method employs the
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Fig. 6. Actual vs. predicted PLS plots for assessing the normalisation of NMR nutri-metabolomics urine data with external validation. Creatinine concentration reference data (mmol/l)
are used to build PLS models following four different normalisation methods: (A) normalisation of the TSP reference signal (0.000 ppm) area; (B) probabilistic quotient normalisation;
(C) normalizationwith respect to the total volume of urine excreted during the 24 h of collection; (D) normalisation to the same vector length (2-Norm). The best normalisationmethod
is chosen on the basis of the performances of the PLS models (in this speciﬁc case the TSP normalisation) evaluated through RMSECV and r2 values.
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the same chance of inﬂuencing the model, whereas pareto scaling
uses the square root of the standard deviation as the scaling factor
which emphasizes the more intense metabolites (van den Berg et al.,
2006). Autoscaling is predominantly used with the metabolic proﬁling
approachwhilemean-centring and pareto scaling aremostly used in re-
lation to themetabolic ﬁngerprinting approach in order to weigh down
noisy signals and baseline noise.
Normalization and scaling methods emphasize different aspects
of the experimental data and each approach has both advantages
and disadvantages. In biological studies the scaling measure can also
be chosen to be dependent on the biological range, on level ranges
or in order to emphasize metabolites that exhibit very minor ﬂuctua-
tions (van den Berg et al., 2006).
10. PCA and unsupervised classiﬁcation
When exploring metabolomics data, the most commonly used
chemometric method is principal component analysis (PCA). The
chance of one metabolite in a biological system containing the maxi-
mum information in data is limited and, with several metabolites
measured, the most information is often a combination of changes
in several metabolites – a so-called metabolite pattern. PCA searches
for common patterns (latent variables) in a data table by establishing
newdirections. This is done by compressing the data table into a lowernumber of variables, called principal components, that maximize the
variance described. The principal components can be used to con-
struct a new coordinate system where the data space is projected so
that the direction of the largest variance becomes the new coordinate
axis. The scores are the projection of the data onto this new coordinate
system, whereas the loadings deﬁne the size of the contribution
of each original variable to the component. PCA performs this in a
hyper-efﬁcient manner by extracting in an unsupervised way a low
number of orthogonal principal components which makes it the
most robust and reliable chemometric method available.
The most important aspect of PCA is that it is unsupervised and
when part of the nutri-metabolomic design can be recovered in
a PCA scoreplot it is considered promising for the whole study
hypothesis. The scoreplot provides a direct and intuitive illustration
of the latent patterns in the data. Objects far apart in the scoreplot
are different with respect to what patterns the model describes
(which metabolites are responsible for the dominating systematic
variation found in data) and objects in close proximity exhibit similar
variations.While PCA extracts themain variation in preprocessed data
there is no guarantee that this variation is reﬂecting the hypothesis
put forward. Measuring metabolites in bioﬂuids from humans pro-
vides data with multiple relevant and irrelevant types of variation
such as gender, eating habits, co-habitation, age, genetics, medication,
environmental factors and life style (Rasmussen et al., 2011). These
variations can, depending on the design of the study, be a major part
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ﬁrst components. Being able to minimize these effects using a proper
experimental design, balanced data, randomized samples and opti-
mized instrumental conditions is of prime importance in nutritional
metabolomic studies where the sought information can otherwise be
hidden.
Fig. 7 shows a typical example of a PCA scoreplot based on the
NMR data from a nutritional metabolomics study. In a PCA model,
the a priori knowledge can be used to colour objects in the scoreplot
thereby emphasizing potential patterns and/or quantitative gradients
found in data. In this case, the scoreplot is coloured by design infor-
mation, i.e. the subject is male or female, and apparently the gender
information dominates the PC2 variation which describes more than
20% of the total systematic variation in the data set. If the hypothesis
is to scrutinize the data for very minor effect it might thus be useful to
divide the data up into two. It is normally not critical to validate a PCA
model since the important scoreplots remain relatively unperturbed
by different validation methods, while the described variance by
the principal components will be inﬂuenced by the validation method
employed.
While a discriminative PCA result is the most important indicator
of whether the design of the study has been effective in revealing
effects, it has a weakness in relation to the interpretation of the result.
Variable (ﬁngerprinting) or metabolite (proﬁling) interpretation has
to be performed through the loading plot, which is the backbone
of the PCA model. However, due to the orthogonality constrain in
the PCA, spectral loadings are typically not easy to interpret. There
are other unsupervised classiﬁcation alternatives to PCA that do
not have this orthogonality constraint. This is for example the case
with multivariate curve resolution (MCR) (de Juan & Tauler, 2006;
Lawton & Sylvestre, 1971) which is similar to PCA, but without the
constraint that the PC must be orthogonal. In simple mixtures MCR
has proven able to recover the real underlying NMR spectra of the in-
dividual components (Winning, Larsen, Bro, & Engelsen, 2008). In the
case of higher order dimension NMR data, such as diffusion ordered
spectroscopy (DOSY), parallel factor analysis (PARAFAC) (Harshman,
1970) can be used to recover the experimental design including the
spectral proﬁles of the metabolites (Bro et al., 2010). The PARAFAC
model has for example been demonstrated useful to resolve the 2D
diffusion-edited 1H NMR spectra of human plasma samples (samples ×
spectral variables × diffusion gradient). In particular PARAFAC was able
to resolve the lipoprotein main fractions due to the different densitiesPC 1 (74%)
PC
 2
 (2
1%
)
Female
Male
Fig. 7. PCA scoreplot based on NMR data from a typical human intervention study.
In this case the scores are coloured by design information (male and female). PC1
describe 74% and PC2 21% of the total variation in the data set.of the lipoproteins. Subsequent inspection of the PARAFAC loadings
shows a remarkable resemblance with the pure fraction methyl spectra
measured by Otvos and co-workers (Otvos et al., 1991), and the diffu-
sion proﬁles give excellent agreement with hydrodynamic diameters
of the main lipoprotein fractions calculated using the Stokes-Einstein
relation for diffusion of a spherical particle (Dyrby et al., 2005). In the
case of recording NMR metabolite proﬁles as a function of time, the
Tucker3 multiwaymodel (Tucker, 1966) has been demonstrated useful
in maintaining more of the structure inherent in the data than PCA by
explicitly model the time as an axis of the development of a toxicologi-
cal response (Dyrby, Baunsgaard, Bro, & Engelsen, 2005). One drawback
of using MCR and PARAFAC in contrast to Tucker3 and PCA is that the
number of components needs to be correctly speciﬁed, which makes
them less suitable for providing an initial overview of data.
11. PLS-DA and supervised classiﬁcation
While PCA is a very powerful explorative method, researchers are
often not satisﬁed by the discrimination that the unsupervised PCA
can provide, for which reason supervised classiﬁcation methods are
employed. In supervised classiﬁcation chemometric methods, the
a priori knowledge is actively used in the classiﬁcation model. Many
different supervised classiﬁcation methods exist, but the archetype
is the so-called partial least squares regression discriminant analysis
(PLS-DA) method (Ståhle & Wold, 1987). The PLS-DA method is a
classiﬁcation method where a classiﬁer variable (typically a vector
with zero's and one's describing the subjects relation to one out of
two classes) is predicted in the best possible way using the informa-
tion found in the metabolite table or the NMR spectral data set. The
desired result of this classiﬁcation exercise is to ﬁnd the best possible
discrimination between two (or more) groups and, in turn, the me-
tabolite pattern that is responsible for the discrimination between
the two groups, for example intervention and control. The PLS-DA
is closely related to a normal partial least squares regression (PLS)
model (Wold, Martens, &Wold, 1983) where, instead, a continuous pa-
rameter (e.g. cholesterol level) is predicted from e.g. a NMR spectrum.
While a normal PLS model is optimized according to the prediction
error (e.g. root-mean-square-error-of-cross-validation: RMSECV), a
PLS-DAmodel should be optimized on the basis of classiﬁcation perfor-
mance (e.g. rate or percentage of misclassiﬁed samples). The use of
PLS-DA models are dominating nutritional metabolomic studies be-
cause of its very strong classiﬁcation performance. This is exempliﬁed
in Fig. 8 which shows a comparison between a PCA score classiﬁcation
and a PLS-DA score classiﬁcation on the same data. In case of the PCA
the design parameter which is metabolome dynamics (0 h or 2 h)
cannot be differentiated in the ﬁrst two PCs describing more than 90%
of the variation in the NMR data. In contrast the PLS-DA scoreplot
shows a clear albeit not perfect classiﬁcation of the time parameter.
While PCA represents an unbiased, untargeted and unsupervised
data exploration, PLS-DA represents the opposite. It is a supervised
methodwhere patterns are extracted so that they discriminate between
classes in the best possible way. “When you ask for discrimination - you
will get it!” and for PLS-DA spurious correlations often can lead to excel-
lent but false classiﬁcations. In fact it can be shown that a non-validated
PLS-DA on sound metabolite data containing no information about a
given class relationship is able to show a clear separation of the classes
in the scoreplot (Westerhuis et al., 2008). Regardless of validation
or not, the score- and loading- plots would be similar and thus, these
plots should not be blindly used to access the classiﬁcation performance
of a PLS-DAmodel. The only acceptable approach is to include a rigorous
validation step to conﬁrm or refute the class separation. The application
of more advanced validationmethods like double cross-validation, per-
mutation and Monte Carlo testing often add complementary insight of
the model performance (Westerhuis et al., 2008). The ultimate classiﬁ-
cation test/validation is the use of an independent test set; i.e. applica-
tion of the developed classiﬁcation model on some new samples, not
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Fig. 8. Comparison of (A) a PCA scoreplot and (B) the PLS-DA scoreplot seeking to discriminate between intervention time states (0 and 2 h). Ellipsoids represent within class
distribution with a coverage of 47% (mean±one standard deviation on each semi axis).
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correctly or not.
12. New data analytical techniques for old problems
In the beginning of the 19th century agricultural experimentation
led Ronald A. Fisher, the father of modern statistics, to develop
analysis of variance (ANOVA) (Fisher, 1918) for analysis of data
from dedicated experimental setups in order to optimally estimate
the effect of e.g. a treatment (compared to a control) with high sta-
tistical power with the least number of samples. Nowadays, in
e.g. nutri-metabolomics, experiments are setup for analysis of the
effect of a certain diet intervention, where the only difference com-
pared to Fishers agricultural experiments, is that the response data is
of a highly complex multivariate nature. This indeed challenges the
data analytical approaches, where of-the-shelf-tools like PCA and
PLS (-DA) have limited capability in utilizing the information from
the experimental design. A series of new tools have been developed
combining the best of the ideas from ANOVA and PCA/PLS, these
are Anova Simultaneous Component Analysis (ASCA) (Smilde et al.,
2005), PARAllel Factor analysis ASCA (PARAFASCA) (Jansen et al.,
2008), MultiLevel PLS-DA (ML-PLS-DA) (van Velzen et al., 2008)
and others. In order to exemplify how these methods work imagine
a simple crossover trial, where n individuals have been treated with
diet A and diet B in a randomized crossover fashion with washout
period etc. At the end of each intervention, the effect x is measured.
If the response is univariate, the difference between the effect of diet
A and diet B is naturally tested by a paired t-test. The power of a
paired t-test is that each subject serves as its own control and the
variation sources in x is hence split into what origins from the indi-
vidual subjects and what origins from the treatment. More formally
the model of x can be written as
xi ¼ α treatmentið Þ þ β subjectið Þ þ ei
where α has k levels (the number of treatments) and β has j levels
(the number of subjects). ei is the error term which often is assumed
normally distributed. In a full cross over design ei has kj levels. In
a testing scenario, the aim is to compare the effect i.e. differences
between different levels of α with spread in (random) error. If
the response is multivariate it is possible to similarly split the infor-
mation into different blocks. Take the setup from above, but let theresponse be multivariate (X). The model of X can be formalized as
follows:
X ¼ Xtreatment þ Xsubject þ E
For a full crossover the dimension of the X's is kj by p (p=the
number of variables). Xtreatment describes the information related to
the different treatments, and has k levels (rank k) while Xsubject de-
scribes the between subject variation (j levels, rank j). E represents
the nonsystematic information. In human intervention studies the
variation related to the individual subjects is often orders of magni-
tudes bigger than the variation related to treatment, which makes
this split powerful in focusing on the aim (treatment) of the experi-
ment. The right-hand side of Eq. (2) can be combined or analyzed
individually by PLS (ML-PLS-DA) and PCA (ASCA). Assume that X is
made of NMR proﬁles, then a PCA on Xtreatment would point towards
spectral patterns that discriminate between treatments, likewise a
PCA on Xsubject reﬂects where the largest variation due to subject dif-
ferences (age, gender etc.) is distributed. If the aim is to investigate
treatment related patterns (taking the error spread into account) a
score plot from a PCA on Xtreatment+E would reﬂect the treatment
differences in relation to the unexplained variation in data. I.e. ex-
cluding subject speciﬁc variation due to e.g. males being different
than females. If the aim is to test for differences, multivariate classiﬁ-
cation models can be built on relevant parts of Eq. (2). For example a
PLS-DA on Xtreatment+E for classiﬁcation of treatments would point
towards how strong the treatment related variation is compared
to the random variation (ML-PLS-DA). The present example corre-
sponds to a crossover trial but the ideas do not limit to such. For
example, experiments where the effect is monitored during the inter-
vention period (repeated measures) or where design factors are
assumed to interact can also be formalized similarly to Eq. (2) and
subsequently analyzed by relevant component models. ML-PLS-DA
has been successfully applied to nutritional metabolomics studies
such as for example the discrimination of urine metabolic proﬁles
after intake of polyphenol-rich extracts fromwine and grapes as com-
pared to placebo (van Dorsten et al., 2010).
13. The quest for more classiﬁcation performance
Despite the powerful performance of PLS-DA, even more sophisti-
cated methods are being used in nutritional metabolomics in order to
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terventions. In order to improve the interpretation of the classiﬁcation
results, some classiﬁcationmethods include an orthogonalisation step
as an integral part of themodelling. Themost commonly usedmethod
in metabolomics within this category is orthogonal PLS-DA (Cloarec
et al., 2005). While the ML-PLS-DA approach described above extracts
variation uncorrelated to the class information, but uses external
information in doing so, the O-PLS-DA seeks to extract orthogonal
components of unknown, but irrelevant information in the data-set
(i.e. information that is uncorrelated to the classiﬁer that is being
predicted). While O-PLS-DA sometimes result in an easier and more
intuitive interpretation, it will never provide a better classiﬁcation
of the samples (Tapp & Kemsley, 2009). If an improved classiﬁcation
performance is required other classiﬁcation strategies such as for
example canonical variates analysis (CVA) and its extension that
is able to handle datasets with more variables than objects: extended
canonical variates analysis (ECVA) (Nørgaard, Bro, Westad, & Engelsen,
2006) can be investigated. However, it should be noticed that there
will not necessarily be a large difference in the misclassiﬁcation rate
between different methods as they all have their advantages and
disadvantages.
Another obvious approach to improve classiﬁcation performance
and interpretation is to use variable selection. Due to the vast amount
of variables or metabolites included in nutri-metabolomic studies
many of them will be irrelevant (unsystematic, noisy or metabolites
containing different information than the one explored) and removal
of those variable can often lead to improved classiﬁcation models.
Variable selection is a whole branch of chemometrics and outside
the scope of this paper but can give, in relation to nutritional
metabolomic studies, considerable advantages in interpretation and
performance. However, when combining a supervised model such as
PLS-DAwith a “hard core” variable selectionmethodmodel validation
becomes critical. In this contextwewill onlymention the “light” inter-
val PLS-DA (iPLS-DA)methodwhich has proven efﬁcient in improving
and simplifying classiﬁcation models of NMR data by breaking the
variable space (ppm scale) up into smaller intervals (either consisting
of a spectral region with many metabolites or one metabolite per
interval) of data (Di Anibal, Callao, & Ruisanchez, 2011; Ferrari, Foca,
Vignali, Tassi, & Ulrici, 2011; Nørgaard et al., 2000; Savorani,
Kristensen, et al., 2010; Savorani, Picone, et al., 2010; Savorani,
Tomasi, et al., 2010; Winning et al., 2009). Fig. 9 shows an example
of a so-called iPLS plot in which a continuous reference parameter is
to be predicted from a set of NMR spectra – in this case the chylomi-
cron concentration but it could also be a classiﬁer variable. The plot33.544.555.5
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Fig. 9. The application of interval PLS to a large NMR data set for the prediction of the chylom
models (RMSECV as bars). Certain intervals beat the performance of a global 3 componentshows that some intervals improve the global prediction (horizontal
line) in terms of a lower RMSECV and the best one is not surprisingly
the complex lipoprotein methylene peak, here coloured in green
between 1.0 and 1.5 ppm. Consistently, another interval still related
to lipoprotein triglyceride protons and located between 2.0 and
2.5 ppm performs similarly. The principle behind this strategy is to re-
duce the variable space (the intervals can as one extreme be sized one
variable) and thus the number of possible interferences resulting in a
more parsimonious and often improved model. The interval models
are generally a healthy principle in NMR ﬁngerprinting splitting up
different region of the NMR spectrum into logical and more homoge-
nous regions such as the aromatic, carbohydrate and aliphatic regions.
When few intervals and/or fewermetabolites are found to provide the
same or better classiﬁcation as the complete metabolite proﬁle, this
also makes the subsequent biological interpretation simpler.
14. Misclassiﬁcations and the receiver operating characteristics
Despite application of the most powerful classiﬁcation models, the
classiﬁcation performance in a nutritional metabolomic investigation
is rarely complete and there is no doubt that we have to improve our
capability to accept that our metabolomics study failed to show the
effect that we were looking for. Unfortunately, is it seen much too
often that a O-PLS-DA score plot provides the ﬁnal proof of a highly
desired relation, but this is not a valid approach. In order to validate
the performance of a binary classiﬁer, one can use the receiver-
operating characteristic (ROC) which is a common tool within medi-
cine for judging the quality of a metric used to separate two groups in
a population (Zweig & Campbell, 1993). Especially in discrimination
problems with unbalanced numbers in each class, the ROC gives
a more reﬁned description of the performance compared to e.g. a
single metric as the overall miss classiﬁcation rate. In a two group
population, any continuous (numeric) observation, x, may show a
signiﬁcantly different distribution between the groups. It could for
example be the PLS-DA prediction of the intervention kinetics of the
same data as in Fig. 8B. In this case 0 represent 0 h and 1 represent
2 h. Based on the value of x a sample is then classiﬁed into one of the
two groups by comparison with a certain threshold (y). Observations
where xby will be assigned to one group (0 h) and the remainder to
the other (2 h). In this situation, the classiﬁcation of any observation
may be sorted into one of four categories, those correctly assigned
to their group, known as true-positives and -negatives, and those
erroneously assigned to the incorrect group, known as false-positives
and -negatives. Depending on the threshold value and the overlap and0.511.522.5
33333333
pm
icron concentration. The iPLS plot shows the performance of the local interval based PLS
model based on the entire spectrum (horizontal line).
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four categories are often summarised as sensitivity: the proportion of
true positives to true positives plus false negatives; and speciﬁcity:
the proportion of true negatives to true negatives plus false positives.
The ROC can be used to summarise this intrinsic trade-off between
sensitivity and speciﬁcity by plotting the sensitivity vs. speciﬁcity for
the entire range of possible threshold values.
Fig. 10 shows the ROC curve for the intervention study represented
by the PLS-DA model in Fig. 8B. A ROC curve that runs along the
diagonal of the plot classiﬁes the samples randomly, while any curve
that extends into the upper left half improves on this. In the example
we want to predict if the samples belong to 0 or the 2 h class. The
PLS-DA predictions give rise to two proﬁles (coloured in green and
grey-green) which are overlapped and thus no selection of threshold
value y is possible for perfect classiﬁcation. If we select a very low y
we obtain a very high sensitivity but a low speciﬁcity (situation A)
and vice versawhenwe select a high ywe obtain a very low sensitivity
but a high speciﬁcity (situation B). The optimal threshold value is
situation C which has both high sensitivity and high speciﬁcity.
15. Biological interpretation
Metabolite identiﬁcation is an essential part of most metabolomic
studies, but since this task is difﬁcult and a time consuming step
at the end of the metabolomics pipeline, it is sometimes ignored
or left unﬁnished (Scalbert et al., 2009). However, since NMR is of
relative low sensitivity, most NMR nutritional metabolomic studies
include full or near full assignments of metabolite signals. A valuable
aid in metabolite identiﬁcation is the development of human
metabolome databases such as the Biological Magnetic Resonance
Data Bank (Wishart et al., 2009) and in hyphenated NMR techniques
such as LC-NMR which is capable of isolating single compounds and
obtaining pure metabolite spectra (Jaroszewski, 2005). The NMR
technique can elucidate chemical structures and provide highly spe-
ciﬁc evidence for the identiﬁcation of an unknown molecule, if they
are at a high enough quantity (Moco et al., 2007). When a metabolite
or pattern of metabolites has been identiﬁed, a relevant biological in-
terpretation should be drawn related to the research question. This is
still the major challenge in the nutritional metabolomics chain since
the extracted important metabolite patterns responsible for the clas-
siﬁcation may not have direct (causal) relations to the experimental1
0
1
Se
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itiv
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B
Fig. 10. Receiver operator characteristics (ROC) from a PLS-DA model for two class discrimin
speciﬁcity and classiﬁcation threshold boundary. (A) Low threshold boundary leading to high
but low sensitivity. (C) Optimal threshold boundary balancing focus on both speciﬁcity anddesign, but merely be part of the inherent biological pleiothrophy
wheremanymetabolites are inﬂuenced by the perturbation introduced.
If comprehensive biological knowledge is available for the investigated
subjects, the so-called statistical total correlation spectroscopy (STOCSY)
autocorrelation matrices (Cloarec et al., 2005; Eads & Noda, 2002)
and statistical hetero spectroscopy (SHY) for a generalized correlation
approach (Crockford et al., 2006; Noda, 1993) can also be described as
tools for unravelling molecules connected in a metabolic pathway. In
any case it is necessary to validate the found correlations with evidence
from other sources as statistical methods cannot discriminate between
causal effects and indirect correlations (Capozzi et al., 2011).
Nutritional metabolomics is still a relative new technology and
few thorough investigations and successful intervention studies
have reached the scientiﬁc literature. The major advantage of NMR
metabolomics is it inherent quantitative nature and its ability of
providing an unbiased overview over the study design. This is not
possible with the other analytical platform used in nutritional
metabolomics. NMR nutri-metabolomics can in a snapshot provide
an overview over a few hundred metabolites which will enhance
the value of future nutritional intervention studies since it readily
can detect compliance status in relation to: medicine (Loo et al.,
2012), alcohol (Bock, 1982), protein intake (Rasmussen et al., 2012),
fasting status (Nicholson et al., 1984; Rubio-Aliaga et al., 2011), fat
boosting (Cheng et al., 2010), and fruit intake (Heinzmann et al.,
2010). Alone the fact that NMR, in contrast to the other analytical
metabolomics platforms, contains information about the lipoprotein
proﬁle (Otvos et al., 1991; Petersen et al., 2005) and chylomicron
content (Savorani, Kristensen, et al., 2010; Savorani, Picone, et al.,
2010; Savorani, Tomasi, et al., 2010), justiﬁes its relevance. These
molecules are of outmost importance to future obesity and diabetes
research. Many other biomarkers for different food ingestion have
been discovered, but the breakthrough for metabolomics in relation
to describing the mechanisms of functional foods is unfortunately
still missing and therefore the target of forthcoming research studies
in the ﬁeld of nutritional-metabolomics.
16. Conclusion
Nutritional metabolomic studies are complex and studies dealing
with metabolomics data are concerned with multifactorial problems
and as these are analysed with multifactorial sensors and separation0Specificity
Calibrated
CV
ation of a typical dietary intervention. Depicted are three relations between sensitivity/
sensitivity, but low speciﬁcity. (B) High threshold boundary leading to a high speciﬁcity
sensitivity.
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Fig. 11. Superimposed NMR spectra of human blood showing the lipid region of a typical nutri-metabolomic intervention study. Male and female proﬁles are highlighted in different
colours showing a distinct difference in their lipoprotein response to the intervention study.
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and describe the data. The modern analytical platforms generate
vast amount of data in a very short time and the analyst risks the
challenge to be ﬂooded with non-informative data. There are multiple
ways to analyse nutritional metabolomics data and many choices
have to be made. Data recording, cleaning, preprocessing, modeling
and validation are all essential parts of the informatics ﬂow in any nu-
tritional metabolomic study (Fig. 1). More research along this direc-
tion will facilitate data fusion between different nutri-metabolomic
studies which in turn will increase the information level in nutritional
metabolomics.
The NMR analytical platform has several advantages compared
to the other metabolomics analytical platforms. In particular it is in-
herently quantitative which makes it able to provide an unbiased
overview of the metabolome in which hundreds of metabolites
can be simultaneously quantiﬁed in future nutritional metabolomic
studies. Another important aspect of NMR nutri-metabolomics is its
speed of analysis. This property facilitates closely spaced “real-time”
nutritional metabolomics studies (van Ommen et al., 2009) which
will provide much more information related to the new health deﬁ-
nition i.e. the ability to recover after a given perturbation. Last but
not least the non-destructive analysis and the sensitivity of NMR
to physical phenomena such as the rotational diffusion (size) of the
lipoproteins which makes it able to determine the lipoprotein proﬁle
in human blood and in turn to determine the health status (Otvos
et al., 1991; Petersen et al., 2005). Fig. 11 shows the NMR spectra
from a typical human intervention study which reveals not only large
variations in the lipoprotein signals but also major differences in the
average female and male lipoprotein proﬁle.
Technically the NMR analytical platform can still improve and the
expanding number of qNMR applications over the last years can for a
major part be attributed to the introduction of cryoprobes. This allowed
for a cost-effective leap in sensitivity which could previously only
be obtained by investing in very expensive strong superconducting
magnets. The next leaps in sensitivity can be achieved by advances
in probe-design (Grimes & O'Connell, 2011) and introduction of cost-
effective solutions for dynamic nuclear polarisation (DNP).
While nutritional metabolomics canmeasure what has happened to
the human metabolome when ingesting a given diet, nutri-genomics
contains information about the potential of what can happen with the
human metabolome when exposed to a given diet. Hopefully the com-
bined research efforts in nutri-metabolomics will pave the way to the
ultimate challenge of integrating the different -omics technologies:
genomics, transcriptomics, proteomics, and metabolomics, to obtain
a more complete picture of health status and in this way to unravellinks between disease prevention and dietary intake. The new develop-
ments in nutritional metabolomics such as improved analytical tools
and databases combined with bioinformatics, pathway mapping,
and computational modeling, are now used for nutrition research
on diet, metabolism, microbiome, and health associations. These
new developments enable metabolome-wide association studies
(MWAS) (Holmes et al., 2008) and provide a foundation for nutri-
tional metabolomics, along with genomics, epigenomics, and health
phenotyping, to support the integrated models required for person-
alized diet and nutrition forecasting (Jones, Park, & Ziegler, 2012).
Indeed, recent nutritional metabolomic research has shown that an
understanding of metabolic phenotypes and individual differences in
the response to food challenges is a prerequisite for guiding nutrition
and health programmes (Heinzmann et al., 2012).Acknowledgments
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